AEPGX | LAAGX | AEPGX / LAAGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 41 years | 4 years | - |
Gain YTD | 0.577 | 0.727 | 79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1500 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 126B | 2.89M | 4,361,371% |
Annual Yield % from dividends | 1.49 | 0.42 | 352% |
Returns for 1 year | 1.87 | 13.20 | 14% |
Returns for 3 years | -13.86 | -7.46 | 186% |
Returns for 5 years | 0.76 | N/A | - |
Returns for 10 years | 23.64 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HAGCX | 51.61 | 0.91 | +1.79% |
Carillon Eagle Mid Cap Growth C | |||
VYMYX | 19.68 | 0.26 | +1.34% |
Voya Mid Cap Research Enhanced Index W | |||
FBTAX | 27.83 | 0.33 | +1.20% |
Fidelity Advisor Biotechnology A | |||
RCEYX | 56.80 | 0.59 | +1.05% |
Victory RS Large Cap Alpha Y | |||
FERAX | 10.58 | 0.03 | +0.28% |
First Eagle Global Real Assets A |